1. Development of tacrolimus eye drops voluntarily suspended

   Media release 09 February 2013 Pages: 2 - 2

2. EMEA recommends suspension of Bextra marketing in the EU

   Media release 09 February 2013 Pages: 2 - 2

3. Cumulative dexamethasone dose a risk factor for avascular necrosis

   Clinical study 09 February 2013 Pages: 3 - 3

4. Greater QTc interval prolongation with droperidol a myth?

   Clinical study 09 February 2013 Pages: 3 - 3

5. Greater weight increases with olanzapine than with risperidone

   Clinical study 09 February 2013 Pages: 4 - 4

6. Less upper GI damage with etoricoxib than other NSAIDs

   Clinical study 09 February 2013 Pages: 4 - 4

7. Amifostine offers protection against melphalan-induced mucositis

   Clinical study 09 February 2013 Pages: 5 - 5

8. Antipsychotics increase risk of lipid metabolism disorders in younger patients

   Clinical study 09 February 2013 Pages: 5 - 5

9. Rofecoxib, not other RA treatments, may increase CHF risk

   Clinical study 09 February 2013 Pages: 5 - 5

10. Sedative effect of antipsychotics impairs patients' well-being

    Clinical study 09 February 2013 Pages: 5 - 5

11. BCG vaccine

    Case report 09 February 2013 Pages: 6 - 6

12. Bezafibrate interaction

    Case report 09 February 2013 Pages: 6 - 6

13. Bortezomib

    Case report 09 February 2013 Pages: 6 - 6

14. Carbamazepine interaction

    Case report 09 February 2013 Pages: 6 - 7

15. Carbamazepine/valproic acid

    Case report 09 February 2013 Pages: 7 - 7

16. Celecoxib

    Case report 09 February 2013 Pages: 7 - 8

17. Ciclosporin/isoflurane/nicorandil

    Case reports 09 February 2013 Pages: 8 - 8

18. Ciclosporin/tacrolimus

    Case report 09 February 2013 Pages: 8 - 8

19. Codeine

    Case report 09 February 2013 Pages: 8 - 8

20. Diclofenac/interferon-β-1a

    Case reports 09 February 2013 Pages: 8 - 9

21. Enoxaparin sodium

    Case report 09 February 2013 Pages: 9 - 9

22. Eptifibatide

    Case reports 09 February 2013 Pages: 9 - 10

23. Esomeprazole

    Case report 09 February 2013 Pages: 10 - 10

24. Everolimus

    Case reports 09 February 2013 Pages: 10 - 10

25. Fentanyl

    Case report 09 February 2013 Pages: 10 - 11

26. Fluphenazine

    Case report 09 February 2013 Pages: 11 - 11

27. Glatiramer acetate

    Case report 09 February 2013 Pages: 11 - 11

28. Hepatitis A vaccine inactivated/hepatitis B vaccine recombinant

    Case reports 09 February 2013 Pages: 11 - 12

29. Herbal medicines

    Case report 09 February 2013 Pages: 12 - 12

30. Infliximab

    Case report 09 February 2013 Pages: 12 - 12

31. Interferon-α

    Case report 09 February 2013 Pages: 12 - 13

32. Interferon-β-1b

    Case report 09 February 2013 Pages: 13 - 13

33. Lamotrigine

    Case report 09 February 2013 Pages: 13 - 13

34. Linezolid

    Case reports 09 February 2013 Pages: 13 - 13

35. Lopinavir/ritonavir

    Case report 09 February 2013 Pages: 14 - 14

36. Methotrexate

    Case report 09 February 2013 Pages: 14 - 14

37. Milnacipran

    Case report 09 February 2013 Pages: 14 - 14

38. Nicorandil

    Case report 09 February 2013 Pages: 14 - 15

39. Oxaliplatin

    Case report 09 February 2013 Pages: 15 - 15

40. Phenytoin

    Case report 09 February 2013 Pages: 15 - 15

41. Propofol

    Case report 09 February 2013 Pages: 15 - 15

42. Ritodrine

    Case report 09 February 2013 Pages: 15 - 16

43. Sibutramine

    Case reports 09 February 2013 Pages: 16 - 16

44. Simvastatin

    Case reports 09 February 2013 Pages: 16 - 16

45. Sulfadiazine

    Case report 09 February 2013 Pages: 16 - 17

46. Tacrolimus

    Case report 09 February 2013 Pages: 17 - 17

47. Tacrolimus

    Case report 09 February 2013 Pages: 17 - 17

48. Thioridazine overdose

    Case report 09 February 2013 Pages: 17 - 17

49. Tretinoin

    Case report 09 February 2013 Pages: 18 - 18

50. Triptorelin

    Case report 09 February 2013 Pages: 18 - 18